Are you doing Pharmacogenetic testing?

1 year ago

EMQN’s Pharmacogenetics External Quality Assessment (EQA) scheme is currently accepting registrations for the 3rd year of the EQA scheme.

The scheme offers independent assessment of genotyping results and clinical interpretation of 3 cases and is open to laboratories using panel and/or single gene work flows. One of the cases will include DPYD testing, which was recently recommended by EMA. Availability to participate on the scheme is limited and registration closes on 30th March 2021!

Find out more here, or contact us by emailing

Next: Online Individual Assessment for classification of BRCA1 and BRCA2 variants 2021 (Run 6)
Translate »